• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境蛋白质组学:来自多发性骨髓瘤的经验教训

Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma.

作者信息

Fernando Rodrigo Carlini, de Carvalho Fabrício, Leme Adriana Franco Paes, Colleoni Gisele Wally Braga

机构信息

Department of Experimental and Clinical Oncology, Discipline of Hematology and Hemotherapy, Federal University of São Paulo, UNIFESP, São Paulo, Brazil.

Laboratory of Mass Spectrometry, Laboratory of National Biosciences, LNBio, National Council for Research in Energy and Materials (CNPEM), Campinas, Brazil.

出版信息

Front Oncol. 2021 Mar 23;11:563384. doi: 10.3389/fonc.2021.563384. eCollection 2021.

DOI:10.3389/fonc.2021.563384
PMID:33833982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8021918/
Abstract

Although the "seed and soil" hypothesis was proposed by Stephen Paget at the end of the 19th century, where he postulated that tumor cells (seeds) need a propitious medium (soil) to be able to establish metastases, only recently the tumor microenvironment started to be more studied in the field of Oncology. Multiple myeloma (MM), a malignancy of plasma cells, can be considered one of the types of cancers where there is more evidence in the literature of the central role that the bone marrow (BM) microenvironment plays, contributing to proliferation, survival, migration, and drug resistance of tumor cells. Despite all advances in the therapeutic arsenal for MM treatment in the last years, the disease remains incurable. Thus, studies aiming a better understanding of the pathophysiology of the disease, as well as searching for new therapeutic targets are necessary and welcome. Therefore, the present study aimed to evaluate the protein expression profiling of mononuclear cells derived from BM of MM patients in comparison with these same cell types derived from healthy individuals, in order to fill this gap in MM treatment. Proteomic analysis was performed using the mass spectrometry technique and further analyses were done using bioinformatics tools, to identify dysregulated biological pathways and/or processes in the BM microenvironment of patients with MM as a result of the disease. Among the pathways identified in this study, we can highlight an upregulation of proteins related to protein biosynthesis, especially chaperone proteins, in patients with MM. Additionally, we also found an upregulation of several proteins involved in energy metabolism, which is one of the cancer hallmarks. Finally, with regard to the downregulated proteins, we can highlight mainly those involved in different pathways of the immune response, corroborating the data that has demonstrated that the immune system of MM is impaired and, therefore, the immunotherapies that have been studied recently for the treatment of the disease are extremely necessary in the search for a control and a cure for these patients who live with the disease.

摘要

尽管“种子与土壤”假说是19世纪末由斯蒂芬·佩吉特提出的,他假定肿瘤细胞(种子)需要适宜的介质(土壤)才能形成转移,但直到最近肿瘤微环境才开始在肿瘤学领域得到更多研究。多发性骨髓瘤(MM)是一种浆细胞恶性肿瘤,可被视为文献中更多证据表明骨髓(BM)微环境起核心作用的癌症类型之一,它有助于肿瘤细胞的增殖、存活、迁移和耐药性。尽管近年来MM治疗的治疗手段有了诸多进展,但该疾病仍然无法治愈。因此,旨在更好地理解该疾病病理生理学以及寻找新治疗靶点的研究是必要且受欢迎的。因此,本研究旨在评估MM患者骨髓来源的单核细胞与健康个体来源的相同细胞类型的蛋白质表达谱,以填补MM治疗中的这一空白。使用质谱技术进行蛋白质组学分析,并使用生物信息学工具进行进一步分析,以确定MM患者骨髓微环境中因疾病导致的失调生物途径和/或过程。在本研究确定的途径中,我们可以突出显示MM患者中与蛋白质生物合成相关的蛋白质上调,特别是伴侣蛋白。此外,我们还发现参与能量代谢的几种蛋白质上调,能量代谢是癌症特征之一。最后,关于下调蛋白质,我们可以主要突出那些参与免疫反应不同途径的蛋白质,这证实了已证明MM免疫系统受损的数据,因此,最近研究的用于治疗该疾病的免疫疗法对于寻求控制和治愈这些患有该疾病的患者极为必要。

相似文献

1
Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma.肿瘤微环境蛋白质组学:来自多发性骨髓瘤的经验教训
Front Oncol. 2021 Mar 23;11:563384. doi: 10.3389/fonc.2021.563384. eCollection 2021.
2
Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.靶向骨髓微环境中的免疫龛:多发性骨髓瘤免疫治疗的兴起。
Curr Cancer Drug Targets. 2017;17(9):782-805. doi: 10.2174/1568009617666170214103834.
3
Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets.多发性骨髓瘤细胞系和原发性肿瘤蛋白质组:蛋白质生物合成与免疫系统作为潜在治疗靶点
Genes Cancer. 2015 Nov;6(11-12):462-471. doi: 10.18632/genesandcancer.88.
4
Proteomic analysis of the bone marrow microenvironment in extramedullary multiple myeloma patients.骨髓外多发性骨髓瘤患者骨髓微环境的蛋白质组学分析。
Neoplasma. 2022 Mar;69(2):412-424. doi: 10.4149/neo_2021_210527N715. Epub 2022 Jan 18.
5
Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.免疫疗法在靶向多发性骨髓瘤骨髓微环境中的作用:一种不断发展的治疗策略。
Pharmacotherapy. 2017 Jan;37(1):129-143. doi: 10.1002/phar.1871. Epub 2017 Jan 6.
6
Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.骨髓基质细胞诱导多发性骨髓瘤的耐药性。
Int J Mol Sci. 2020 Jan 17;21(2):613. doi: 10.3390/ijms21020613.
7
The microenvironment and molecular biology of the multiple myeloma tumor.多发性骨髓瘤肿瘤的微环境和分子生物学。
Adv Cancer Res. 2011;110:19-42. doi: 10.1016/B978-0-12-386469-7.00002-5.
8
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
9
Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model.使用基于混合多尺度智能体的模型预测联合疗法对骨髓瘤细胞生长的影响。
Oncotarget. 2017 Jan 31;8(5):7647-7665. doi: 10.18632/oncotarget.13831.
10
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1.破骨细胞在多发性骨髓瘤中的免疫抑制作用:程序性细胞死亡配体 1 的作用。
Front Immunol. 2018 Aug 10;9:1822. doi: 10.3389/fimmu.2018.01822. eCollection 2018.

引用本文的文献

1
Advances in small extracellular vesicles: roles in the tumor microenvironment and epithelial ovarian cancer diagnosis and treatment.小细胞外囊泡的研究进展:在肿瘤微环境及上皮性卵巢癌诊断与治疗中的作用
Front Oncol. 2025 Feb 11;15:1526944. doi: 10.3389/fonc.2025.1526944. eCollection 2025.
2
Wireless radiation and health: making the case for proteomics research of individual sensitivity.无线辐射与健康:为个体敏感性的蛋白质组学研究提供依据。
Front Public Health. 2025 Jan 10;12:1543818. doi: 10.3389/fpubh.2024.1543818. eCollection 2024.
3
Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review.

本文引用的文献

1
lncRNA ST3GAL6‑AS1 promotes invasion by inhibiting hnRNPA2B1‑mediated ST3GAL6 expression in multiple myeloma.lncRNA ST3GAL6-AS1 通过抑制 hnRNPA2B1 介导的 ST3GAL6 表达促进多发性骨髓瘤的侵袭。
Int J Oncol. 2021 Apr;58(4). doi: 10.3892/ijo.2021.5185. Epub 2021 Mar 2.
2
Isocitrate dehydrogenase 3A, a rate-limiting enzyme of the TCA cycle, promotes hepatocellular carcinoma migration and invasion through regulation of MTA1, a core component of the NuRD complex.异柠檬酸脱氢酶3A是三羧酸循环的限速酶,它通过调节MTA1(核小体重塑去乙酰化酶复合物的核心成分)来促进肝细胞癌的迁移和侵袭。
Am J Cancer Res. 2020 Oct 1;10(10):3212-3229. eCollection 2020.
3
多发性骨髓瘤进展中的蛋白质组学改变:综述
Diagnostics (Basel). 2023 Jul 10;13(14):2328. doi: 10.3390/diagnostics13142328.
4
Clinical Considerations for Immunoparesis in Multiple Myeloma.多发性骨髓瘤免疫球蛋白缺乏症的临床考量
Cancers (Basel). 2022 May 3;14(9):2278. doi: 10.3390/cancers14092278.
The 60-kDa heat shock protein regulates energy rearrangement and protein synthesis to promote proliferation of multiple myeloma cells.
60kDa 热休克蛋白调节能量重排和蛋白质合成,促进多发性骨髓瘤细胞增殖。
Br J Haematol. 2020 Sep;190(5):741-752. doi: 10.1111/bjh.16569. Epub 2020 Mar 10.
4
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches.B 细胞成熟抗原(BCMA)在多发性骨髓瘤中的作用:靶向治疗的原理和当前的治疗方法。
Leukemia. 2020 Apr;34(4):985-1005. doi: 10.1038/s41375-020-0734-z. Epub 2020 Feb 13.
5
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma.α-烯醇化酶(ENO1)作为多发性骨髓瘤新型免疫代谢靶点的临床前验证。
Oncogene. 2020 Mar;39(13):2786-2796. doi: 10.1038/s41388-020-1172-0. Epub 2020 Feb 5.
6
Heat shock proteins as a new, promising target of multiple myeloma therapy.热休克蛋白作为多发性骨髓瘤治疗的一个新的、有前途的靶点。
Expert Rev Hematol. 2020 Feb;13(2):117-126. doi: 10.1080/17474086.2020.1711730. Epub 2020 Jan 23.
7
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.嵌合抗原受体修饰 T 细胞疗法在多发性骨髓瘤中的应用:超越 B 细胞成熟抗原。
Front Immunol. 2019 Jul 16;10:1613. doi: 10.3389/fimmu.2019.01613. eCollection 2019.
8
Role of the RAB7 Protein in Tumor Progression and Cisplatin Chemoresistance.RAB7蛋白在肿瘤进展和顺铂化疗耐药中的作用。
Cancers (Basel). 2019 Aug 1;11(8):1096. doi: 10.3390/cancers11081096.
9
Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism.多发性骨髓瘤患者间充质干细胞的转录组分析显示,细胞周期进程、免疫反应和骨代谢相关基因下调。
Sci Rep. 2019 Jan 31;9(1):1056. doi: 10.1038/s41598-018-38314-8.
10
Metabolic Features of Multiple Myeloma.多发性骨髓瘤的代谢特征。
Int J Mol Sci. 2018 Apr 14;19(4):1200. doi: 10.3390/ijms19041200.